Ads
related to: complicated vs uncomplicated gonorrhea
Search results
Results From The WOW.Com Content Network
Gonorrhea if left untreated may last for weeks or months with higher risks of complications. [19] One of the complications of gonorrhea is systemic dissemination resulting in skin pustules or petechia, septic arthritis, meningitis, or endocarditis. [19] This occurs in between 0.6 and 3% of infected women and 0.4 and 0.7% of infected men. [19]
Gonorrhea is the second-most common sexually ... that everyone should be concerned about acquiring drug-resistant forms of gonorrhea because it is more difficult and complicated to treat. He adds ...
Then in 1883, Max Bockhart proved conclusively that the bacterium isolated by Albert Neisser was the causative agent of the disease known as gonorrhea by inoculating the penis of a healthy man with the bacteria. [9] The man developed the classic symptoms of gonorrhea days after, satisfying the last of Koch's postulates. Until this point ...
Gonococcemia (also known as "Disseminated gonococcal infection" [1]) is a rare complication of mucosal Neisseria gonorrhoeae infection, or Gonorrhea, that occurs when the bacteria invade the bloodstream. [2] It is characterized by fever, tender hemorrhagic pustules on the extremities or the trunk, migratory polyarthritis, and tenosynovitis. [3]
[4] [needs update] Uncomplicated SSSIs included "simple abscesses, impetiginous lesions, furuncles, and cellulitis." [ 4 ] Complicated SSSIs included "infections either involving deeper soft tissue or requiring significant surgical intervention, such as infected ulcers, burns, and major abscesses or a significant underlying disease state that ...
It has been easy to test for the presence of gonorrhea by viewing a Gram stain of the urethral discharge under a microscope: The causative organism is distinctive in appearance; however, this works only with men because other non-pathogenic gram-negative microbes are present as normal flora of the vagina in women. Thus, one of the major causes ...
Key clinical trials for delafloxacin have been performed by Melinta regarding indications for skin and skin structure infections as well as complicated bacterial infections and uncomplicated gonorrhea. The trial on gonorrhea was terminated before data was released. [9]
Uncomplicated urinary tract infections (including cystitis) Complicated urinary tract infections (restricted use) [9] Uncomplicated urethral and cervical gonorrhea (however this indication is no longer considered to be effective by some experts due to bacterial resistance) [10] [11] Prostatitis due to Escherichia coli. [12]